- Notification that Quarterly Report will be submitted late (NT 10-Q)
10 November 2009 - 9:08AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 12b-25
NOTIFICATION
OF LATE FILING
(Check One)
:
¨
Form
10-K
¨
Form
20-F
¨
Form
11-K
x
Form
10-Q
¨
Form
N-SAR
¨
Form
N-CSR
For
Period Ended:
September 30, 2009
[_]
Transition Report on Form
10-K
[_]
Transition Report on Form
20-F
[_]
Transition Report on Form
11-K
[_]
Transition Report on Form
10-Q
[_]
Transition Report on Form
N-SAR
For the
Transition Period
Ended: ________________________________________
Read
attached instruction sheet before preparing form. Please Print
or Type.
Nothing
in this form shall be construed to imply that the Commission has verified
any information contained herein.
|
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
|
|
PART
I
REGISTRANT
INFORMATION
Full
Name of Registrant
|
American
Oriental Bioengineering, Inc.
|
|
Former
Name if Applicable
|
|
|
Address
of Principal Executive Office
(Street and
Number)
|
1
Liangshuihe First Avenue, Beijing E-Town Economic and Technology
Development Area, E-Town
|
City,
State and Zip Code
|
Beijing
100176, People’s Republic of China
|
|
PART
II
RULES
12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
x
|
(a)
The reasons described in reasonable detail in Part III of this form could
not be eliminated without unreasonable effort or expense;
(b)
The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, 11-K, Form N-SAR or From N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report of transition report on Form
10-Q, or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART
III
NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR,
N-CSR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
The report of American Oriental
Bioengineering, Inc. (the “Company”) on Form 10-Q could not be filed within the
prescribed time period due to the fact that the Company was unable to finalize
its financial results as well as the disclosure requirements of Form 10-Q
without unreasonable expense or effort. As a result, the Company’s auditors were
unable to complete their review of the Form 10-Q prior to the due date of the
report.
PART
IV
OTHER
INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
|
|
Mitchell
S. Nussbaum, Esq.
|
|
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months (or for such shorter) period
that the registrant was required to file such reports) been
filed? If answer is no, identify report(s).
|
x
Yes
¨
No
|
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
|
o
Yes
x
No
|
|
If
so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
|
|
|
|
|
American
Oriental Bioengineering, Inc.
|
(Name
of Registrant as Specified in
Charter)
|
Has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
Date:
November 9, 2009
|
By:
/s/ Tony
Liu
Name: Tony
Liu
Title: Chief
Executive Officer and Chairman
|
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about American Oriental Bioengineering, Inc. (New York Stock Exchange): 0 recent articles
More News Articles